Literature DB >> 22112851

Altered expression of inflammation-related genes in human carotid atherosclerotic plaques.

Maria Donata Di Taranto1, Alberto Morgante, Umberto Marcello Bracale, Francesco Paolo D'Armiento, Massimo Porcellini, Giancarlo Bracale, Giuliana Fortunato, Francesco Salvatore.   

Abstract

OBJECTIVE: Inflammation is a pivotal process in atherosclerosis development and progression, but the underlying molecular mechanisms remain largely obscure. We have conducted an extensive expression study of atherosclerotic plaques to identify the inflammatory pathways involved in atherosclerosis.
METHODS: We studied 11 human carotid plaques, their respective adjacent regions and 7 control arteries from different subjects. Expression of 92 genes was studied by TaqMan low-density array human inflammation panel. Human aortic endothelial and smooth muscle cells were used for in vitro experiments.
RESULTS: The mRNA levels of 44/92 genes (48%) differed significantly between the tissues examined (13 up-regulated and 31 down-regulated). Dysregulated genes encode molecules belonging to different functional classes although most of them encode enzymes involved in the eicosanoid synthesis pathway. The expression of PTGIS and PTGIR genes was decreased in human aortic endothelial and smooth muscle cells stimulated with oxLDL and TNF-α.
CONCLUSIONS: This study not only reveals several dysregulated genes in human lesions but also focuses the role played by the genes involved in the eicosanoid synthesis pathway during atherosclerotic development. The decrease of PTGIS and PTGIR expression after oxLDL treatment mirrors the decreased mRNA levels in atherosclerotic lesions versus control arteries, which suggests that oxidation is important for PTGIS and PTGIR regulation in human vessel cells during atherosclerosis development.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112851     DOI: 10.1016/j.atherosclerosis.2011.10.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Gene expression profiling of coronary artery disease and its relation with different severities.

Authors:  Shiridhar Kashyap; Sudeep Kumar; Vikas Agarwal; Durga P Misra; Shubha R Phadke; Aditya Kapoor
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

2.  IL-24 gene polymorphisms are associated with cardiometabolic parameters and cardiovascular risk factors but not with premature coronary artery disease: the genetics of atherosclerotic disease Mexican study.

Authors:  Gilberto Vargas-Alarcón; Carlos Posadas-Romero; Teresa Villarreal-Molina; Edith Alvarez-León; Javier Angeles-Martinez; Rosalinda Posadas-Sanchez; Irma Monroy-Muñoz; Sergio Luna-Fuentes; Carmen González-Salazar; Julian Ramirez-Bello; Guillermo Cardoso-Saldaña; Aida Medina-Urrutia; Eric Kimura-Hayama
Journal:  J Interferon Cytokine Res       Date:  2014-02-19       Impact factor: 2.607

3.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

4.  TNF-α induces acyl-CoA synthetase 3 to promote lipid droplet formation in human endothelial cells.

Authors:  Hye Seung Jung; Masami Shimizu-Albergine; Xia Shen; Farah Kramer; Dan Shao; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Rong Tian; Jenny E Kanter; Karin E Bornfeldt
Journal:  J Lipid Res       Date:  2019-11-13       Impact factor: 5.922

5.  Oxidized low-density lipoprotein suppresses expression of prostaglandin E receptor subtype EP3 in human THP-1 macrophages.

Authors:  Xuxia Sui; Yanmin Liu; Qi Li; Gefei Liu; Xuhong Song; Zhongjing Su; Xiaolan Chang; Yingbi Zhou; Bin Liang; Dongyang Huang
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

6.  Expandable Arterial Endothelial Precursors from Human CD34+ Cells Differ in Their Proclivity to Undergo an Endothelial-to-Mesenchymal Transition.

Authors:  Auston Z Miller; Alexander Satchie; Alex P Tannenbaum; Aman Nihal; James A Thomson; David T Vereide
Journal:  Stem Cell Reports       Date:  2018-01-09       Impact factor: 7.765

7.  Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage.

Authors:  Ljubica Perisic Matic; Maria Jesus Iglesias; Mattias Vesterlund; Mariette Lengquist; Mun-Gwan Hong; Shanga Saieed; Laura Sanchez-Rivera; Martin Berg; Anton Razuvaev; Malin Kronqvist; Kent Lund; Kenneth Caidahl; Peter Gillgren; Fredrik Pontén; Mathias Uhlén; Jochen M Schwenk; Göran K Hansson; Gabrielle Paulsson-Berne; Erika Fagman; Joy Roy; Rebecka Hultgren; Göran Bergström; Janne Lehtiö; Jacob Odeberg; Ulf Hedin
Journal:  JACC Basic Transl Sci       Date:  2018-08-01

8.  Treatment of de novo femoro-popliteal lesions with a new Drug Coated Balloon: early experience of a single Center in the first 50 patients.

Authors:  U M Bracale; M Di Filippo; A De Capua; L Vanni; D Narese; F Pecoraro; A M Giribono; R Bracale
Journal:  Transl Med UniSa       Date:  2019-01-20

9.  Inhibitory effect of alpinetin on IL-6 expression by promoting cytosine methylation in CpG islands in the IL-6 promoter region.

Authors:  Ke Hu; Yuxian Li; Minghua Liang; Lijing Liu; Yuefu Chen; Minjiang Huang; Bifeng Tan; Yingquan Luo; Huiming Yin
Journal:  Mol Genet Genomic Med       Date:  2019-11-13       Impact factor: 2.183

10.  Increased expression of fatty acid binding protein 4 and leptin in resident macrophages characterises atherosclerotic plaque rupture.

Authors:  K Lee; M Santibanez-Koref; T Polvikoski; D Birchall; A D Mendelow; B Keavney
Journal:  Atherosclerosis       Date:  2012-10-05       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.